
Opinion|Videos|March 3, 2025
The Role of Different Stakeholders in Optimizing the Uptake of Biosimilars
Panelists discuss how stakeholders can enhance biosimilar uptake through coordinated efforts in financial alignment, patient-centric pricing, professional education, simplified administrative processes, and collaborative data exchange.
Advertisement
Video content above is prompted by the following:
- How can different stakeholders such as providers, health systems, insurance providers, and pharmacy benefit managers work together more efficiently to optimize the uptake of biosimilars?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Government Shutdown Could Disrupt Health Care Access
2
FDA Approves Remibrutinib for Chronic Spontaneous Urticaria
3
AI Seen as Key to Reducing Health Care Claim Denials, Survey Finds
4
White House, Pfizer Reach Agreement on Drug Discounts; Trump Announces TrumpRx
5